【US Stocks Movement】Teladoc Health surged on October 29: Q3 results exceeded expectations, outlook upgraded, and insurance revenue increased

Teladoc Health Soars on October 29: Analysis

Keywords: Q3 results beat expectations, raised guidance, insurance revenue growth

1. After the market closed on October 28, the company reported revenue of $605.1 million for the third quarter of 2026, higher than the consensus estimate of $585.55 million; a loss per share of $0.15, better than the consensus loss of $0.23; adjusted EBITDA was $79.4 million, up 14% year-on-year. The midpoint of 2026 revenue guidance was raised by $13 million to $2.39 to $2.44 billion; the midpoint of adjusted EBITDA guidance was raised by $3 million to $277 million to $303 million, and the 2026 GAAP earnings per share guidance was also raised.

2. The October 28 financial report shows that integrated care business revenue was $398.5 million, up 2% year-on-year; adjusted EBITDA was $75 million, up 13.3% year-on-year. BetterHelp insurance revenue was $32 million, an increase of $10 million quarter-on-quarter, and the annualized insurance business revenue run rate exceeded $140 million. On October 29, BofA Securities raised its target price from $10.50 to $11.50, BMO Capital Markets raised its target from $5 to $7, and Stifel raised its target from $5.5 to $6.5.

(Disclaimer: This content is generated by AI technology summarizing publicly available information for reference only and does not constitute investment advice.)